Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9118)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 8, 2015 (publication date) through Dec 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Puchakayala BK, Verma S, Kanwar P, Hart J, Sanivarapu RR, Mohanty SR. Histopathological differences utilizing the nonalcoholic fatty liver disease activity score criteria in diabetic (type 2 diabetes mellitus) and non-diabetic patients with nonalcoholic fatty liver disease. World J Hepatol 2015; 7(25): 2610-2618 [PMID: 26557954 DOI: 10.4254/wjh.v7.i25.2610] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i25/2610.htm |
| Number | Citing Articles |
| 1 |
Fei Meng, Qin Wu, Wei Zhang, Shirong Hou. Application of Interpretable Machine Learning Models Based on Ultrasonic Radiomics for Predicting the Risk of Fibrosis Progression in Diabetic Patients with Nonalcoholic Fatty Liver Disease. Diabetes, Metabolic Syndrome and Obesity 2023; : 3901 doi: 10.2147/DMSO.S439127
|
| 2 |
Abbas Ali Tasneem, Nasir Hassan Luck, Zain Majid. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Tropical Doctor 2018; 48(2): 107 doi: 10.1177/0049475517742261
|
| 3 |
Simona Cernea. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. Life 2024; 14(2): 272 doi: 10.3390/life14020272
|
| 4 |
Carlo Bruno Giorda, Gabriele Forlani, Roberta Manti, Arianna Mazzotti, Salvatore De Cosmo, Maria Chiara Rossi, Antonio Nicolucci, Paolo Di Bartolo, Antonio Ceriello, Pietro Guida, Barbara Tartaglino, Giuseppina Russo. Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients. Diabetes Research and Clinical Practice 2018; 135: 65 doi: 10.1016/j.diabres.2017.10.023
|
| 5 |
Rocío Aller de la Fuente, Natalia Mora Cuadrado, Carla Tafur, Juan Jose López Gómez, Sara Gómez de la Cuesta, María Concepción García Sánchez, Beatriz Antolin Melero, Daniel Antonio de Luis Román. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes. Endocrinología, Diabetes y Nutrición (English ed.) 2018; 65(6): 354 doi: 10.1016/j.endien.2018.05.009
|
| 6 |
Fabio Nascimbeni, Stefano Ballestri, Mariana Verdelho Machado, Alessandro Mantovani, Helena Cortez-Pinto, Giovanni Targher, Amedeo Lonardo. Clinical relevance of liver histopathology and different histological classifications of NASH in adults. Expert Review of Gastroenterology & Hepatology 2018; 12(4): 351 doi: 10.1080/17474124.2018.1415756
|
| 7 |
Alessandro Mantovani, Giovanni Targher, Giacomo Zoppini. Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes. Clinics in Geriatric Medicine 2020; 36(3): 527 doi: 10.1016/j.cger.2020.04.010
|
| 8 |
Jinying Xia, Guang Jin, Qifeng Hua, Shihan Cui, Jianhui Li. Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.917304
|
| 9 |
|
| 10 |
Ovidiu Paul Calapod, Andreea Maria Marin, Anca Pantea Stoian, Carmen Fierbinteanu-Braticevici. Clinical Model for the Prediction of Severe Liver Fibrosis in Adult Patients with Type II Diabetes Mellitus. Diagnostics 2022; 12(8): 1829 doi: 10.3390/diagnostics12081829
|
| 11 |
Martine C. Morrison, Robert Kleemann, Arianne van Koppen, Roeland Hanemaaijer, Lars Verschuren. Key Inflammatory Processes in Human NASH Are Reflected in Ldlr−/−.Leiden Mice: A Translational Gene Profiling Study. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00132
|
| 12 |
Rocío Aller, Rebeca Sigüenza, María Pina, Cristina Laserna, Beatriz Antolín, Beatriz Burgueño, Miguel Durà, Olatz Izaola, David Primo, Daniel Antonio de Luis. Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor. Endocrine 2020; 68(3): 557 doi: 10.1007/s12020-020-02268-7
|
| 13 |
Ovidiu P. Calapod, Andreea M. Marin, Minodora Onisai, Laura C. Tribus, Corina S. Pop, Carmen Fierbinteanu-Braticevici. The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on COVID-19 Disease Prognosis. Medicina 2021; 57(5): 434 doi: 10.3390/medicina57050434
|
| 14 |
Carlo B. Giorda, Roberta Picariello, Barbara Tartaglino, Elisa Nada, Cristina Linzalata, Francesco Romeo, Giuseppe Costa, Roberto Gnavi. Hepatic fibrosis of any origin in a large population of type 2 diabetes patients. Nutrition, Metabolism and Cardiovascular Diseases 2021; 31(10): 2887 doi: 10.1016/j.numecd.2021.06.020
|
| 15 |
Rocío Aller de la Fuente, Natalia Mora Cuadrado, Carla Tafur, Juan Jose López Gómez, Sara Gómez de la Cuesta, María Concepción García Sánchez, Beatriz Antolin Melero, Daniel Antonio de Luis Román. Histopathological differences in patients with biopsy-proven non-alcoholic fatty liver disease with and without type 2 diabetes. Endocrinología, Diabetes y Nutrición 2018; 65(6): 354 doi: 10.1016/j.endinu.2017.12.011
|
| 16 |
Amanda Souza Silva-Sperb, Helena Abadie Moraes, Bruna Concheski de Moura, Bruna Cherubini Alves, Juliana Paula Bruch-Bertani, Vittoria Zambon Azevedo, Valesca Dall’Alba. Effect of probiotic supplementation in nonalcoholic steatohepatitis patients: PROBILIVER TRIAL protocol. Trials 2019; 20(1) doi: 10.1186/s13063-019-3679-7
|
| 17 |
Jun-Wei Wang, Chun-Hua Jin, Jiang-Feng Ke, Yi-Lin Ma, Yu-Jie Wang, Jun-Xi Lu, Mei-Fang Li, Lian-Xi Li. Serum iron is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes: A real-world study. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.942412
|
| 18 |
Alessandro Mantovani, Giovanni Targher, Christopher D. Byrne. Textbook of Diabetes. 2024; : 820 doi: 10.1002/9781119697473.ch57
|
| 19 |
Claudia B.M. Strey, Luiz A. de Carli, Sérgio R. Pioner, Marciane Fantinelli, Sabrina S. Gobbato, Guilherme F. Bassols, Alexandre Losekann, Gabriela P. Coral. Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese. Annals of Hepatology 2018; 17(4): 585 doi: 10.5604/01.3001.0012.0922
|
| 20 |
Nahum Méndez-Sánchez, Eira Cerda-Reyes, Fátima Higuera-de-la-Tijera, Ana K. Salas-García, Samantha Cabrera-Palma, Guillermo Cabrera-Álvarez, Carlos Cortez-Hernández, Luis A Pérez-Arredondo, Emma Purón-González, Edgar Coronado-Alejandro, Arturo Panduro, Heriberto Rodríguez-Hernández, Vania C. Cruz-Ramón, Alejandro Valencia-Rodríguez, Xingshun Qi, Nashla Hamdan-Pérez, Nancy E. Aguilar-Olivos, Beatriz Barranco-Fragoso, Oscar Ramírez-Pérez, Alfonso Vera-Barajas. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis. F1000Research 2020; 9: 56 doi: 10.12688/f1000research.21918.1
|
| 21 |
Fatih Türker, Tolga Sahın, Alihan Oral, Erdem Koçak, Betül Çavuşoğlu Türker, Adil Niğdelioğlu, Hayriye Esra Ataoğlu Ataoğlu. Evaluation of Predisposing Metabolic Risk Factors for Portopulmonary Hypertension in Patients with NASH Cirrhosis. International Journal of General Medicine 2022; : 859 doi: 10.2147/IJGM.S339474
|
| 22 |
Iben Rix, Julie Steen Pedersen, Heidi Storgaard, Lise Lotte Gluud. Cardiometabolic effects of antidiabetic drugs in non‐alcoholic fatty liver disease. Clinical Physiology and Functional Imaging 2019; 39(2): 122 doi: 10.1111/cpf.12526
|